Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Rev. Soc. Bras. Med. Trop ; 44(5): 631-632, Sept.-Oct. 2011. tab
Article in English | LILACS | ID: lil-602908

ABSTRACT

INTRODUCTION: Laboratory-based surveillance is an important component in the control of vancomycin resistant enterococci (VRE). METHODS: The study aimed to evaluate real-time polymerase chain reaction (RT-PCR) (genes vanA-vanB) for VRE detection on 115 swabs from patients included in a surveillance program. RESULTS: Sensitivity of RT-PCR was similar to primary culture (75 percent and 79.5 percent, respectively) when compared to broth enriched culture, whereas specificity was 83.1 percent. CONCLUSIONS: RT-PCR provides same day results, however it showed low sensitivity for VRE detection.


INTRODUÇÃO: Vigilância com base em detecção laboratorial é um componente importante no controle de enterococos resistentes a vancomicina (ERV). MÉTODOS: Avaliamos procedimento da reação em cadeia da polimerase real time (PCR-RT) (genes vanA-vanB) para detecção de ERV em 115 swabs de pacientes incluídos em um programa de vigilância. RESULTADOS: A sensibilidade do RT-PCR foi semelhante a da cultura primária (75 por cento e 79,5 por cento, respectivamente) quando comparada com a cultura em caldo enriquecido, enquanto a especificidade foi de 83,1 por cento. CONCLUSÕES: O RT-PCR fornece resultados no mesmo dia, contudo mostra baixa sensibilidade para a detecção de VRE.


Subject(s)
Humans , Bacterial Proteins/genetics , Carbon-Oxygen Ligases/genetics , Enterococcus/genetics , Gram-Positive Bacterial Infections/diagnosis , Rectum/microbiology , Vancomycin Resistance/genetics , Enterococcus/isolation & purification , Gram-Positive Bacterial Infections/microbiology , Predictive Value of Tests , Real-Time Polymerase Chain Reaction/methods , Sensitivity and Specificity
2.
Braz. j. infect. dis ; 11(2): 237-239, Apr. 2007. ilus
Article in English | LILACS | ID: lil-454725

ABSTRACT

Detection of AmpC beta-lactamase production by enterobacteria has been problematic. Contrary to ESBLs, no specific guidelines are available for detection and confirmation of AmpC production by clinical relevant microorganisms. Moreover, some bacterial species may produce inducible AmpC beta-lactamases that can be easily overlooked by routine susceptibility tests. We reported here a new test based on the strong inducible effect of imipenem on AmpC genes and the consequent antagonism with ceftazidime. This test is very simple and proved to be helpful in detecting AmpC-inducible enzymes among several species of clinical isolates.


Subject(s)
Humans , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/drug effects , Ceftazidime/pharmacology , Enterobacteriaceae/drug effects , Imipenem/pharmacology , beta-Lactamases/drug effects , Bacterial Proteins/biosynthesis , Bacterial Proteins/genetics , Enterobacteriaceae/enzymology , Phenotype , beta-Lactamases/biosynthesis , beta-Lactamases/genetics
SELECTION OF CITATIONS
SEARCH DETAIL